This action might not be possible to undo. Are you sure you want to continue?
, Speciality Chemicals, Raw Materials, Fine and Specialty Chemicals Intermediates, Pharmaceutical Bulk Drugs
Indian drugs and pharmaceutical industry has advanced perceptibly and is getting ready for the new patent regime and to withstand global competition, which is expected to be unleashed by new winds of liberalisation - a new era of liberalisation much different from what was ushered in since the conclusion of the Uruguay Round and the establishment of the World Trade Organisation. The industry has been expanding at annual rates ranging between 8 to 10% (against global growth rate of 6%). According to a study by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of $25 billion (Rs 1200 billion) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing. The market for bulk drugs and formulations had increased from about Rs 103 billion in 1990-91 to an estimated Rs 435 billion at the end of 2003-04. The prices of Indian essential drugs are among the lowest in the world. Apart from strides made by the industry in the last half-a-century, lower production cost due to reverse engineering and low R&D outlays has been a major factor in keeping the prices under check. The global pharmaceutical industry is estimated at $ 300 billion, not all representing cross-border trade. India's measly share of $ 1.5 billion in global trade represents an untapped potential. Under the regime of economic liberalisation underway since early 1990s, the drugs and pharmaceutical sector witnessed initiatives at fresh investment in the sector. Nearly 1735 investment proposals of the order of around Rs 166 billion were initiated. The foreign collaboration proposals approved numbered around 425 with a foreign direct investment (FDI) component of over Rs 25 billion. The pharmaceuticals have figured high on the export front. In 2001-02, the sector was estimated to have registered a growth of 17.6% at around Rs 20.3 billion. In the wake of economic liberalisation, many a overseas players returned or contemplated returning to India. These include Ivox Corp (USA), Taro
000 registered practitioners of the Indian system of medicine. The fund is used for the development and commercialisation of the new products and applications.000 . MILLIONCs are known to contribute as much as 10% or more of their turnover to R&D. however. MILLIONCs like Rocha. These institutes churn out some 5. Themis Medicare. Torrent Pharma. and on the other. Until recently. Lupin Labs. Wockhardt and Zandu Pharma. top ten companies are known to control over 30% of the market. Ranbaxy Labs. on the one hand. While India is very strong in process chemistry. Lyka Labs. Cipla. The Export Import Bank of India (Exim Bank) had doubled its corpus for the pharmaceutical industry to Rs 2 billion as a result of increased activity in the industry.involving heavy financial outlays. At present there are more than 20. These are out either to set shop or looking for acquisitions in India. The country has over 400. Morepan Labs.B. Aventis and Chiron are making India a regional hub for bulk drugs. The R&D level in the country is low with even well-placed pharma companies spending less than 2% of turnover on R&D. Ayurveda continues to remain a preferred system of medicine for a vast segment of population in the country. Around 170 institutes properly affiliated to various universities impart under. in a highly fragmented industry. antibacterials. Chemicals. J. cardio-vascular and other essential drugs. especially in the external sector. private sector .000 drugs including vitamins. Astrazeneca.Pharmaceuticals (Israel) and Merck (USA). Nicholas Piramal. Sun Pharma. Aventis. significant improvement in the existing design of products. are called for.500 fresh practitioners. initiatives at all levels government.or post-graduate courses each year. Jagsonpal Pharma. academia. Dr. It needs. it has made it possible to supply a near 100. Reddy's. Aurobindo Pharma. setting up and expansion of pilot plants. While each of about 80% of the manufacturers has annual sales below a billion rupees. IPCA Labs. research studies for obtaining regulatory approvals. GlaxoSmithkline. Bayer. cost of filing and managing international patent and R&D Centres. to be recognised that the presence of small scale manufacturers has resulted. biology and applied bio-chemistry. The major players are: Alembic Chem. E-Merck. The practitioners are supported by 12. These account for nearly 37% of the market. antibiotics. FDC. Hexal AG of Germany has established a liaison office in India. Unichem Labs. Kopran. only a few of the Indian companies had gone into any serious R&D activity.000 players in the country. TTK Healthcare. Much of the effort was directed to affordable analogue research.
Each detailed project reports cover all the aspects of business. Many of the engineers. raw materials to forecasting the financial requirements. from analysing the market. Identification and Selection of Plant and Machinery. Please select the projects of your interests. Manufacturing Process and or Equipment required. Technical and Commercial Counseling for setting up new industrial projects on the following topics.100 beds available for ayurveda treatment countrywide. The emerging biotechnology sector has already taken by storm and is offering sops to states to make these as the thriving ground for the highly potential segment in medicare. Preparation of Techno-Economic Feasibility Reports. We can also prepare project report on any subject as per your requirement. Market Surveys and Studies. The scope of the report includes assessing market potential. We also offer self-contained Pre-Investment and Pre-Feasibility Studies. corporate diversification planning etc.dispensaries and 2. project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis. formulating the cash flow statement. investment decision making. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material. We can modify the project capacity and project cost as per your requirement. projecting the balance sheet etc. . General Guidance. negotiating with collaborators. We can provide you detailed project reports on the following topics. confirming availability of various necessities such as plant & machinery.
Manufacturing Techniques: Formulae Detailed Process of Manufacture. investment decision making. Properties. Project Cost.Project Report & Profiles The detailed project profile reports cover all the aspects of business. Cost of Land & Building. Instruments. Projected Balance Sheet. Cost of Production. Electrification. Financial Aspects: Cost of Raw Materials. Capital Formation. Built up Area. Depreciation Chart. Land Man Ratio. Profitability Analysis. corporate diversification planning etc. Uses & Applications. Cost / Rates of Raw Materials. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material. projecting the balance sheet etc. Rates of the Land. from analysing the market. Cost of Plant & Machineries. Electric Load and Water. Land & Building: Requirement of Land Area. BIS (Bureau of Indian Standard) Specifications & Requirements. Cash Flow Statement for 5 to 10 Years. Brief History of the Product. Personnel Requirements: Requirement of Staff & Labour. Market Survey: Present Market Position. Export Prospect. Suppliers / Manufacturers of Plant and Machineries. Flow Sheet Diagram. Break Even Point. Statistics of Imports & Exports. Plant Location. Each Detailed Project Report Contains Beginning: Project Introduction. Maintenance. Working Capital. formulating the cash flow statement. Properties of Raw Materials. Availability of Raw Materials. negotiating with collaborators. Laboratory Equipment's and Accessories. Personnel Management. Fixed Capital Investment. Names and Addresses of Existing Units (Present Manufactures). Expected Future Demand. confirming availability of various necessities such as plant & machinery. The DPR is prepared by highly qualified and experienced consultants and the market research and analysis are supported by a panel of experts and computerised data bank. Construction Schedule. Raw Material: List of Raw Materials. . Plant & Machinery: List of Plant & Machineries.Conclusion. The scope of the report includes assessing market potential. raw materials to forecasting the financial requirements. Required Quality of Raw Materials. Plant Layout. Miscellaneous Items and Accessories. Skilled & Unskilled Labour.
This action might not be possible to undo. Are you sure you want to continue?
We've moved you to where you read on your other device.
Get the full title to continue listening from where you left off, or restart the preview.